Bourne Lent Asset Management Inc Pacific Biosciences Of California, Inc. Transaction History
Bourne Lent Asset Management Inc
- $262 Million
- Q4 2024
A detailed history of Bourne Lent Asset Management Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 943,755 shares of PACB stock, worth $1.08 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
943,755
Previous 954,595
1.14%
Holding current value
$1.08 Million
Previous $1.62 Million
6.47%
% of portfolio
0.66%
Previous 0.62%
Shares
25 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
255MCall Options Held
3.05MPut Options Held
1.71M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$41.1 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$26.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$26.7 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$24.3 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$23.3 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $256M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...